Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Andrey Antov"'
Autor:
Eric C. Anderson, John DiPalazzo, F. Lee Lucas, Michael J. Hall, Andrey Antov, Petra Helbig, Jennifer Bourne, Leah Graham, Lory Gaitor, Christine Lu-Emerson, Leslie S. Bradford, Roger Inhorn, Sarah J. Sinclair, Philip L. Brooks, Christian A. Thomas, Karen Rasmussen, Paul K. J. Han, Edison T. Liu, Jens Rueter
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-12 (2024)
Abstract Genomic tumor testing (GTT) is an emerging technology aimed at identifying variants in tumors that can be targeted with genomically matched drugs. Due to limited resources, rural patients receiving care in community oncology settings may be
Externí odkaz:
https://doaj.org/article/dcdaf957786f4e43911da55a8d4b389f
Autor:
Eric C. Anderson, Alexandra C. Hinton, Christine W. Lary, Anny T. H. R. Fenton, Andrey Antov, Emily Edelman, Petra Helbig, Kate Reed, Susan Miesfeldt, Christian A. Thomas, Michael J. Hall, J. Scott Roberts, Jens Rueter, Paul K. J. Han, MCGI Working Group
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Purpose Large-panel genomic tumor testing (GTT) is an emerging technology with great promise but uncertain clinical value. Previous research has documented variability in academic oncologists’ perceptions and use of GTT, but little is know
Externí odkaz:
https://doaj.org/article/dbabf7f6cf97472f85681b1a23bd2da2
Autor:
Jens Rueter, Anny T. Fenton, Elizabeth Scharnetzki, Emily A Edelman, Kate Reed, Eric C. Anderson, Andrey Antov, Paul K. J. Han
Publikováno v:
Patient Education and Counseling. 104:3-11
Objective To compare clinicians’ and patients’ preferences for disclosure of genomic tumor testing (GTT) results; to determine the sensitivity of these disclosure preferences to uncertainty about the actionability of results; and to explore facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fc660e054a82342f069a6dbada9ec35
https://doi.org/10.1016/j.pec.2020.07.010
https://doi.org/10.1016/j.pec.2020.07.010
Autor:
Alexandra Hinton, Tania D. Strout, Christine W. Lary, Jens Rueter, Eric C. Anderson, Andrey Antov, Paul K. J. Han, Emily A Edelman, Kate Reed, Petra Helbig
Publikováno v:
Psychology, Health & Medicine. 26:805-817
Novel medical technologies, like large-panel genomic tumor testing (GTT), offer great promise but also substantial uncertainty regarding their clinical value and appropriate use. The goal of this study was to understand how clinicians' perceived unce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e1552bcd6ba21ebb591e6e384528fd3
https://doi.org/10.1080/13548506.2020.1764989
https://doi.org/10.1080/13548506.2020.1764989
Autor:
Anneleis Willett, Ryan W. Huey, Aurelio Matamoros, Kevin Kelly, Kunal Sanghavi, Edison T. Liu, Kanwal Pratap Singh Raghav, Michael J. Overman, Cara Statz, N. Dhillon, Scott Kopetz, Andrey Antov, Jens Rueter, Jeannelyn S. Estrella, Jignesh Modha, Gauri R. Varadhachary, Shannon Rowe, Linda Choquette
Publikováno v:
Journal of Clinical Oncology. 38:834-834
834 Background: CUP presents a unique niche and challenge for application of GP. Absence of a primary limits consensus regarding site-directed and availability of tissue specific targeted therapy. We evaluated the real time feasibility and clinical u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45c8b4c696389119c294598a00391bac
https://doi.org/10.1200/jco.2020.38.4_suppl.834
https://doi.org/10.1200/jco.2020.38.4_suppl.834
Autor:
Terence Duane Rhodes, Jens Rueter, Mingshan Cheng, Andrey Antov, Kyle Draheim, Lincoln Nadauld, Honey V. Reddi, Andrew Hesse, Susan D. Airhart, Emily Jocoy, Derrick S. Haslem, Carol J. Bult
Publikováno v:
Journal of Clinical Oncology. 37:e14660-e14660
e14660 Background: Molecular Tumor Boards (MTB) are often the critical decision-making step in identifying genome-guided treatments for patients with difficult-to-treat cancers, e.g. BRAF mutated metastatic colon cancers. A common challenge for MTBs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::265c7ad0c695e8502aa6458c58213572
https://doi.org/10.1200/jco.2019.37.15_suppl.e14660
https://doi.org/10.1200/jco.2019.37.15_suppl.e14660
Autor:
Michael J. Rauh, Gerald Krystal, Laura M. Sly, Frann Antignano, Victor W. Ho, Jens Ruschmann, Etsushi Kuroda, Richard A. Flavell, Andrey Antov, Melisa J. Hamilton
Publikováno v:
The Journal of Immunology. 183:3652-3660
There is a great deal of interest in determining what regulates the generation of classically activated (M1) vs alternatively activated (M2) macrophages (Mφs) because of the opposing effects that these two Mφ subsets have on tumor progression. We s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f9f5d6139b9ebe14ca39dca73da16a2
https://doi.org/10.4049/jimmunol.0900864
https://doi.org/10.4049/jimmunol.0900864
Publikováno v:
Trends in Molecular Medicine. 15:199-207
Differentiation of naïve T cells leads to the generation of T-cell subsets, each possessing distinct cytokine expression profiles for serving different immune functions. Through the activation of separate signaling pathways, this process results in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6377706ddc4fa028dbaad59723ee04b
https://doi.org/10.1016/j.molmed.2009.03.002
https://doi.org/10.1016/j.molmed.2009.03.002
Publikováno v:
Nature reviews. Immunology. 9(2):116-124
Interleukin-12 (IL-12) and IL-4 induce T helper 1 (T(H)1)- and T(H)2-cell differentiation, respectively, in vitro. However, not all T(H)1-cell responses require IL-12 in vivo, and T(H)2-cell responses are remarkably independent of IL-4-receptor signa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::244c675ebfcb994a7e106949e466d69e
https://doi.org/10.1038/nri2488
https://doi.org/10.1038/nri2488
Autor:
Nancy A. Dower, Satoshi Takamatsu, Katrin Layer, Xiaoyu Li, Guosheng Lin, David R. Beier, Alessio Nencioni, Timothy Chevassut, Andrey Antov, Wei Hu, Luk Van Parijs, Stacey L. Stang, Janet E. Buhlmann, James C. Stone, Adam Schmucker, Keith B. Elkon, Roderick T. Bronson, Bing Lim
Publikováno v:
Immunity. 19:243-255
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).This article has been retracted at the request of the Authors.The authors have agreed to retract the paper because of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f2ecf9d8e8f45ee00aa7138a8933c89
https://doi.org/10.1016/s1074-7613(03)00209-7
https://doi.org/10.1016/s1074-7613(03)00209-7